Atlas Trials

Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

Clinical trial NCT00381641 · COMPLETED

Trial details

NCT number
NCT00381641
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland CarcinomaStage III Thyroid Gland Follicular Carcinoma AJCC v7Stage III Thyroid Gland Medullary Carcinoma AJCC v7Stage IV Thyroid Gland Follicular Carcinoma AJCC v7Stage IV Thyroid Gland Medullary Carcinoma AJCC v7Stage IV Thyroid Gland Papillary Carcinoma AJCC v7Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
Start date
2006-08-29
Primary completion
2016-12-31
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.